Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Titan Bio-Tech Ltd. (TITANBIO)
Market Closed
15 Oct, 10:00 PM
MSE
All
(1)
IN
(1)
MSE
Primary
₹
400.
60
+0.65
+0.1625%
₹
17.18B
Market Cap
17.48
P/E Ratio
8%
Div Yield
17,245
Volume
0
Eps
₹
399.95
Previous Close
Watching
Watch
Add Transaction
Day Range
398.25
408
Year Range
171.4
555.65
Want to track
TITANBIO
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Upcoming
TITANBIO
split of 5:4 in 7 days
(23 Oct 2026)
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Titan Bio-Tech Ltd. (TITANBIO) Statistics
Valuation metrics
Market Cap
17.18B
Enterprise value
16.22B
Trailing P/E (ttm)
47.88
Forward P/E
-
PEG ratio
0.88
Price/Sales (ttm)
7.41
Price/Book (mrq)
8.94
Enterprise Value/Revenue
7.41
Enterprise Value/EBITDA
37.14
Overview
Shares outstanding
41.32M
Float
12.66M
Shares short
-
% Held by insiders
0.68%
% Held by institutions
-
Average volume (10 days)
18.67K
Average volume (90 days)
22.61K
Price summary
52-Week low
171.4
52-Week high
555.65
Beta
0.37
50-Day moving average
401.49
200-Day moving average
426.79
Dividends and splits
Forward annual dividend rate
8
Forward annual dividend yield
0.0183%
Trailing annual dividend rate
0.5
Trailing annual dividend yield
0.0013%
5-Year annual dividend yield
0.43%
Payout ratio
0.06
Dividend Date
22 Sep 2026
Ex-Dividend Date
22 Sep 2026
Last split factor
5:1
Last split Date
20 Feb 2026
Financials
Fiscal year
Fiscal year ends
31 Mar 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.15%
Operating margin
0.17%
Operational effectiveness
Return on assets
0.16%
Return on equity
0.19%
Income Statement
Revenue (ttm)
1.93B
Revenue per share (ttm)
52.97
Quarterly revenue growth (yoy)
0.48%
Gross profit (ttm)
985.82M
EBITDA
373.7M
Net income to common (ttm)
272.03M
Diluted EPS (ttm)
8.2
Quarterly earnings growth (yoy)
0.94%
Balance Sheet
Total cash (mrq)
35.99M
Total cash per share (mrq)
0.45
Total debt (mrq)
88.5M
Total Debt/Equity (mrq)
0.03
Current ratio (mrq)
3.28%
Book value per share (mrq)
43.94
Cash Flow
Cash flow statement
197.75M
Levered free cash flow (LFCF)
215.32M